News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,970 Results
Type
Article (47428)
Company Profile (299)
Press Release (684227)
Multimedia
Podcasts (86)
Webinars (16)
Section
Business (209519)
Career Advice (2196)
Deals (36074)
Drug Delivery (118)
Drug Development (82522)
Employer Resources (192)
FDA (16472)
Job Trends (15303)
News (353256)
Policy (33383)
Tag
Academia (2746)
Academic (2)
Accelerated approval (14)
Adcomms (26)
Allergies (109)
Alliances (51144)
ALS (128)
Alzheimer's disease (1558)
Antibody-drug conjugate (ADC) (173)
Approvals (16509)
Artificial intelligence (379)
Autoimmune disease (39)
Automation (23)
Bankruptcy (367)
Best Places to Work (11825)
BIOSECURE Act (20)
Biosimilars (134)
Biotechnology (198)
Bladder cancer (112)
Brain cancer (39)
Breast cancer (411)
Cancer (3312)
Cardiovascular disease (270)
Career advice (1851)
Career pathing (35)
CAR-T (214)
CDC (40)
Cell therapy (567)
Cervical cancer (28)
Clinical research (68157)
Collaboration (1202)
Company closure (4)
Compensation (830)
Complete response letters (37)
COVID-19 (2737)
CRISPR (69)
C-suite (475)
Cystic fibrosis (120)
Data (3639)
Decentralized trials (2)
Denatured (36)
Depression (80)
Diabetes (379)
Diagnostics (6635)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (48)
Drug discovery (170)
Drug pricing (144)
Drug shortages (29)
Duchenne muscular dystrophy (171)
Earnings (89409)
Editorial (47)
Employer branding (25)
Employer resources (163)
Events (118163)
Executive appointments (914)
FDA (18596)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1070)
Gene editing (152)
Generative AI (28)
Gene therapy (441)
GLP-1 (876)
Government (4730)
Grass and pollen (5)
Guidances (330)
Healthcare (19236)
HIV (43)
Huntington's disease (33)
IgA nephropathy (49)
Immunology and inflammation (188)
Immuno-oncology (12)
Indications (45)
Infectious disease (2932)
Inflammatory bowel disease (166)
Inflation Reduction Act (12)
Influenza (76)
Intellectual property (154)
Interviews (347)
IPO (16816)
IRA (50)
Job creations (3851)
Job search strategy (1572)
Kidney cancer (13)
Labor market (67)
Layoffs (544)
Leadership (24)
Legal (8096)
Liver cancer (84)
Longevity (11)
Lung cancer (484)
Lymphoma (244)
Machine learning (21)
Management (62)
Manufacturing (506)
MASH (108)
Medical device (13710)
Medtech (13727)
Mergers & acquisitions (20060)
Metabolic disorders (952)
Multiple sclerosis (111)
NASH (22)
Neurodegenerative disease (156)
Neuropsychiatric disorders (37)
Neuroscience (2374)
NextGen: Class of 2025 (6722)
Non-profit (4662)
Now hiring (54)
Obesity (476)
Opinion (248)
Ovarian cancer (112)
Pain (140)
Pancreatic cancer (141)
Parkinson's disease (202)
Partnered (24)
Patents (363)
Patient recruitment (254)
Peanut (53)
People (60018)
Pharmaceutical (70)
Pharmacy benefit managers (21)
Phase I (21211)
Phase II (30005)
Phase III (22331)
Pipeline (2369)
Policy (237)
Postmarket research (2644)
Preclinical (9267)
Press Release (72)
Prostate cancer (160)
Psychedelics (42)
Radiopharmaceuticals (261)
Rare diseases (527)
Real estate (6247)
Recruiting (73)
Regulatory (23536)
Reports (61)
Research institute (2490)
Resumes & cover letters (375)
Rett syndrome (11)
RNA editing (12)
RSV (57)
Schizophrenia (108)
Series A (176)
Series B (134)
Service/supplier (14)
Sickle cell disease (71)
Special edition (21)
Spinal muscular atrophy (151)
Sponsored (35)
Startups (3799)
State (2)
Stomach cancer (15)
Supply chain (86)
Tariffs (71)
The Weekly (48)
Vaccines (894)
Venture capital (61)
Weight loss (300)
Women's health (53)
Worklife (19)
Date
Today (60)
Last 7 days (436)
Last 30 days (2113)
Last 365 days (31423)
2025 (21732)
2024 (35943)
2023 (40860)
2022 (51925)
2021 (56499)
2020 (54898)
2019 (47645)
2018 (35936)
2017 (33084)
2016 (32665)
2015 (38767)
2014 (32375)
2013 (27536)
2012 (29798)
2011 (30535)
2010 (29032)
Location
Africa (800)
Alabama (71)
Alaska (7)
Arizona (265)
Arkansas (14)
Asia (40131)
Australia (6587)
California (8568)
Canada (2641)
China (776)
Colorado (364)
Connecticut (362)
Delaware (224)
Europe (87423)
Florida (1273)
Georgia (295)
Hawaii (3)
Idaho (61)
Illinois (695)
India (40)
Indiana (408)
Iowa (18)
Japan (260)
Kansas (116)
Kentucky (33)
Louisiana (17)
Maine (65)
Maryland (1142)
Massachusetts (6313)
Michigan (282)
Minnesota (523)
Mississippi (4)
Missouri (102)
Montana (28)
Nebraska (25)
Nevada (98)
New Hampshire (70)
New Jersey (2353)
New Mexico (30)
New York (2342)
North Carolina (1229)
North Dakota (10)
Northern California (3874)
Ohio (262)
Oklahoma (16)
Oregon (35)
Pennsylvania (1808)
Puerto Rico (17)
Rhode Island (41)
South America (1173)
South Carolina (43)
South Dakota (1)
Southern California (3278)
Tennessee (139)
Texas (1327)
United States (31394)
Utah (256)
Virginia (211)
Washington D.C. (79)
Washington State (709)
West Virginia (4)
Wisconsin (85)
731,970 Results for "kannalife sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Kannalife Secures Funding of $1.49 Million from The Michael J. Fox Foundation for Parkinson’s Research
Kannalife Sciences, Inc. is pleased to announce it has been awarded funding of $1,493,409 million from The Michael J. Fox Foundation for Parkinson’s Research.
June 25, 2024
·
4 min read
Press Releases
CV Sciences, Inc. Reports Second Quarter 2025 Financial Results
August 13, 2025
·
13 min read
Business
Washington’s Life Sciences Scene Moves Beyond Research Roots
Washington has had notable life sciences job growth over the past 10 years, according to a Life Science Washington report. The association’s CEO and a biopharma CEO discuss what makes the state stand out, including its talent pool, AI leadership and entrepreneurship support.
August 21, 2025
·
5 min read
·
Angela Gabriel
Business
New York City’s Life Sciences Scene Grows in Stature
New York City has seen increased life sciences employment during the past decade as public funding and key projects like JLABS @ NYC have given the area a boost. A Partnership Fund for New York City executive discusses the city’s strengths and a notable challenge facing businesses.
September 11, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
September 10, 2025
·
6 min read
Press Releases
CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025
August 8, 2025
·
3 min read
Job Trends
California’s $23.9M in Life Sciences Grants Could Add 10,000 Jobs in LA Area
Four Los Angeles County life sciences projects are receiving funding to support goals that include adding jobs, creating multitenant facilities for graduation-stage companies, financially supporting emerging businesses and attracting large employers to the area.
September 10, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Britannia Life Sciences Inc. Announces $10 Million Debenture Offering to Provide Investor Access to Asset-Backed Loan Portfolio
July 28, 2025
·
5 min read
Press Releases
CV Sciences, Inc. Reports First Quarter 2025 Financial Results
May 15, 2025
·
13 min read
Job Trends
Massachusetts’ Life Sciences Job Growth Flattens After 10+ Years of Increases: Report
Massachusetts’ life sciences jobs grew by just 0.03% in 2024, according to a new MassBioEd report. Still, the report found encouraging signs for the industry, noting it’s expected to grow by 11.6% by 2029, adding an estimated 16,633 net new positions.
June 4, 2025
·
3 min read
·
Angela Gabriel
1 of 73,197
Next
